Print

PerkinElmer, Inc. (PKI) Expands Reagent Portfolio to Accelerate Biotherapeutics Drug Development  
12/11/2012 10:24:44 AM

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of a new range of assay kits utilizing AlphaLISA® technology to help improve the safety testing, manufacturing and quality control of biotherapeutic drugs.
//-->